IncreMental Advantage Initiates Coverage of The Immune Response Corporation with Price Target of $0.09 Per Share, Accumulate Rating The Immune…
Response Biomedical Corp. (OTCBB: RPBIF) & (TSX.V: RBM) Response Biomedical Completes US Distribution Network For RAMP Cardiovascular Products US Distributors…
IMNR - The Immune Response Corporation Immune Response Vaccines: The Immune Response vaccines differ from the conventional vaccines in that…
EGDI – Elgrande International, Inc.Elgrande International (OTCBB: EGDI) has a winning team in place. Michael F. Holloran - President and…
StockGuru Welcomes The Immune Response Corporation (OTCBB: IMNR) View the StockGuru Profile for The Immune Response Corporation: http://www.stockguru.com/profiles/imnr/ The Immune…
IMNR - The Immune Response Corporation IncreMental Advantage, an equity research firm, has initiated coverage of The Immune Response Corporation…
IMNR - The Immune Response CorporationThe Immune Response Corporation was founded in 1986 by Dr. Jonas Salk, the developer of…
07/23/2006 VOLUME 248 Companies featured in the current edition of the newsletter: ADSX, ASPN, CDGT, CPPT, EMIS, ENZ, FLWE, FSN,…
IMNR - The Immune Response CorporationImportant Phase IIb Trials Set to Begin for MS Treatment - NeuroVax NeuroVax Phase IIb…
IMNR - The Immune Response CorporationImmune Response has its own state-of-the-art manufacturing plant in King of Prussia, Pennsylvania, to make…